covid19 Tracker

Covid-19 Vaccine Watch

Vaccine Distribution Globally

Top 10 Countries with highest vaccine doses administered


Percentage of Fully Vaccinated Population in Countries


India's Vaccine Diplomacy

Export Composition

Number of vaccine doses (in Million) given to COVAX


Vaccines undergoing Clinical Trials in India

Phase 1 Phase 2 Phase 3 Approved for Emergency Use
Name: Bharat Biotech: BBV154,
Description: Non Replicating Viral vector,
Study Group: 18-60 years
Name: Gennova Biopharmaceuticals Limited: HGCO19,
Description: RNA-based,
Study Group: 18-75 years
Name: Zydus Cadila: ZyCoV-D,
Description: DNA-based,
Study Group: 12+ years
Name: Moderna mRNA - 1273,
Description: RNA-based,
Name: Biological E Limited: BECOV2D,
Description: Protein Subunit,
Study Group: 18-65 years
Name: SII: COVOVAX,
Description: Protein Subunit,
Study Group: 18+ years
Name: Bharat Biotech: Covaxin,
Description: Inactivated virus,
Name: Biological E Limited: BECOV2A,
Description: Protein Subunit,
Study Group: 18-65 years
Name: Novavax: NVX-CoV2373,
Description: Protein Subunit,
Study Group: 18+ years
Name: SII: Covishield,
Description: Non Replicating Viral vector,
Name: Bharat Biotech: Covaxin - Paediatric Study,
Description: Inactivated virus,
Study Group: Age 2-18 years
Name: Oxford/AstraZeneca: AZD1222,
Description: Non Replicating Viral vector,
Name: Gamaleya: Sputnik V,
Description: Non Replicating Viral vector,

Covid-19 Immunization Initiative in India

India

44,61,56,659

Vaccine Doses

Doses per 1000 people: 325.34

Source: Ministry of Health & Family Welfare

Vaccine doses administered in the past 7 days


A Spotlight on the Vaccine Distribution

 

All Countries SHOW